EMLA Cream vs. Other Topical Creams
EMLA cream is not the same as other topical creams such as hydrocortisone cream. EMLA is a eutectic mixture of local anesthetics (lidocaine 2.5% and prilocaine 2.5%) specifically designed for topical anesthesia, while hydrocortisone is a corticosteroid used to reduce inflammation.
Composition and Mechanism of Action
EMLA cream contains:
- Lidocaine 2.5%
- Prilocaine 2.5%
- Formulated as an oil-in-water emulsion 1
Mechanism of action:
- Both lidocaine and prilocaine are amide-type local anesthetics
- They stabilize neuronal membranes by inhibiting ionic fluxes required for impulse initiation and conduction
- The eutectic mixture allows both anesthetics to be liquid at room temperature, enhancing skin penetration 1
Clinical Uses
EMLA cream is indicated for:
- Local analgesia on normal intact skin 1
- Anesthesia of genital mucous membranes for superficial minor surgery 1
- Pretreatment for infiltration anesthesia 1
- Prevention of pain from needle punctures or incisions 2
- Management of pain associated with venipuncture or intravenous cannulation 3
- Dermatological procedures like curettage of molluscum contagiosum lesions and split-skin graft harvesting 3
In contrast, hydrocortisone cream is used for:
- Inflammatory skin conditions 2
- Treatment of xerotic skin reactions 2
- Management of inflammatory lesions 2
Application and Onset
EMLA requires:
- Application under occlusive dressing for at least 1 hour for procedures like intravenous catheter placement
- At least 2 hours for procedures like split-skin graft harvesting
- Satisfactory dermal analgesia is achieved 1 hour after application, reaches maximum at 2-3 hours, and persists for 1-2 hours after removal 1
- Faster onset (5-10 minutes) when applied to genital mucosa 1
In comparison, hydrocortisone and other topical anti-inflammatory creams:
- Do not provide anesthesia
- Work by reducing inflammation rather than blocking nerve impulses
- May take days to show full therapeutic effect 2
Contraindications and Precautions
EMLA cream should not be used in:
- Patients with allergy to amide anesthetics
- Non-intact skin
- Patients with congenital or idiopathic methemoglobinemia
- Infants aged <12 months receiving treatment with methemoglobin-inducing agents 4
- Near the eyes or on open wounds 1
- When penetration beyond the tympanic membrane is possible due to ototoxic effects 1
Safety Considerations
EMLA can cause methemoglobinemia, a serious condition requiring prompt treatment 1
Risk factors for systemic toxicity include:
- Excessive amount of EMLA
- Large application area
- Prolonged application time
- Diseased or inflamed skin
- Age less than 3 months
- Prematurity
- Concomitant use of methemoglobin-inducing agents 5
EMLA should be used with caution in:
Efficacy Comparison
Research shows that EMLA is superior to other topical anesthetics:
- In a randomized comparative trial, EMLA demonstrated better efficacy than 10% lidocaine cream regarding anesthesia onset and duration 6
- For acceptable pain at 4-mm depth, EMLA required 40.88 minutes of application compared to 45.38 minutes for 10% lidocaine 6
Clinical Implications
When choosing between EMLA and other topical creams:
Consider the primary goal:
- For anesthesia/pain control: EMLA is appropriate
- For inflammation: Hydrocortisone or other corticosteroid creams
Consider application time:
- EMLA requires 1-2 hours under occlusive dressing for full effect
- Hydrocortisone may require days of regular application
Consider safety profile:
- EMLA has risks of methemoglobinemia and systemic toxicity
- Hydrocortisone has risks of skin thinning with prolonged use
Consider the specific procedure:
- For needle procedures, minor surgeries: EMLA is preferred
- For inflammatory skin conditions: Hydrocortisone is preferred
In summary, EMLA cream and hydrocortisone cream are fundamentally different medications with distinct mechanisms of action, indications, and safety profiles.